期刊文献+

蓝藻抗病毒蛋白-N的制备、生物活性鉴定及其多克隆抗体的制备和修饰

Purification of Cyanovirin-N with antiviral activity and preparation as well as modification of its polyclonal antibody
下载PDF
导出
摘要 目的:纯化CVN重组蛋白,检测其抗病毒活性,制备CVN多克隆抗体,并对其进行纯化和修饰。方法:利用两步Ni-NTA亲和层析和一步SUMO酶切制备CVN抗原,CPE法观察其抗病毒活性,活性抗原免疫新西兰白兔制备多克隆抗体,ELISA及Western blot鉴定其效价和特异性,抗血清经硫酸铵初步沉淀和DEAE离子交换层析获得纯化抗体,纯化抗体通过辣根过氧化物酶(HRP)标记获得修饰抗体。结果:纯化获得纯度达95%以上且具有明显抗流感病毒作用的非融合CVN,利用所得CVN抗原成功制备CVN多克隆抗体,酶联免疫分析显示其效价达到1∶16 000以上,Western blot分析表明其具明显特异性。抗血清经盐析和DEAE离子柱层析后获得效价为1∶6 400高纯度纯化抗体,经HRP修饰后获得具有较高生物活性的标记抗体。结论:获得高纯度,高效价兔抗CVN多克隆抗体,以及HRP标记的兔抗CVN多克隆抗体,为后续研究奠定了基础。 AIM: To purify the recombinant Cyanovirin-N(CVN) and determine its anti-influenza virus A(H1N1) activity,and to prepare the polyclonal antibody of CVN,purify it and label it with an enzyme for future application.METHODS: The recombinant CVN were rapidly purified by two rounds of Ni-NTA chelating chromatography intervened with a SUMO protease cleavage step.Anti-H1N1 activity of CVN was determined using cytopathogenic effect assay(CPE).The rabbits were immunized with the purified CVN and the antibody was identified by ELISA and Western blot.IgG was purified by ammonium sulfate precipitation followed by DEAE chromatography and the purified IgG was labeled by HRP.RESULTS: The purity of the obtained CVN protein which showed obvious Anti-H1N1 activity in vitro was higher than 95%.The polyclonal antibody of CVN was successfully produced in the rabbits and the results of ELISA and Western blot showed that the antiserum had high titer and high specificity.The purified antibody with a titer up to 1∶6 400 was successfully obtained and the anti-CVN antibody-HRP conjugate was achieved after labeling the purified antibody with HRP.CONCLUSION: The purified antibody against CVN has been purified and further coniugated with HRP,with can be used for future research.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2011年第5期531-534,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 国家科技支撑计划资助(2008BA163B05) 国家自然科学基金面上项目(30873082) 暨南大学"211"经费资助(2010)
关键词 CVN 抗病毒活性 多克隆抗体 修饰抗体 CVN antiviral activity polyclonal antibody labeled antibody
  • 相关文献

参考文献11

  • 1Boyd MR, Gustafson KR, McMahon JB, et al. Discovery of cyanovi- fin-N, a novel human immunodeficiency virusinactivating protein that binds viral surface envelope glycoprotein gpl20: potential applications to microbicide development [ J ]. Antimierob Agents Chemother, 1997, 41 : 1521 - 1530.
  • 2Helle F, Wyehowski C, Vu-Dae N, et al. Cyanovirin-N inhibits hep- atitis C virus entry by binding to envelope protein glycans[J]. J Biol Chem, 2006, 281 (35) : 25177 - 25183.
  • 3Smee DF, Wandersee MK, CheckeRs MB, et al. Influenza A ( H1N1 ) virus resistance to eyanovirin-N arises naturally during adap- tation to mice and by passage in cell culture in the presence of the in- hibitor[J]. Antivir Chem Chemother, 2007, 18(6) : 317 -327.
  • 4Barrientos LG, Gronenborn AM. The highly specific carbohydrate-bind- ing protein cyanovirin-N: structure, anti-HIV/Ebola activity and possi- bihties for therapy[J]. Mini Rev Med Chem, 2005, 5( 1 ) : 21 -31.
  • 5Sexton A, Drake PM, Mahmood N, et al. Transgenic plant production of cyanovirin-N, an HIV microbicide[J]. FASEB J, 2006, 20:356 - 358.
  • 6Gao X, Chen W, Guo C, et al. Soluble cytoplasmic expression, rapid purification, and characterization of cyanovirin-N as a His-SUMO fu- sion[J]. Appl Microbiol Biotechnol, 2009, 85(4) : 1051 -1060.
  • 7陈伟,韩波,钱垂文,刘秋英,熊盛.蓝藻抗病毒蛋白-N基因的克隆、表达、纯化及活性鉴定[J].生物工程学报,2010,26(4):538-544. 被引量:8
  • 8张文,刘红军,胡志军,高琰,高志涛,王辉.兔抗凋亡蛋白酶活化因子-1多克隆抗体的制备、纯化与鉴定[J].细胞与分子免疫学杂志,2009,25(1):68-69. 被引量:1
  • 9Xiong S, Fan J, Kitazato K. The antiviral protein eyanovirin-N: the current state of its produetian and applications [ J ]. Appl Mierobiol Biotechnol, 2010, 86 (3) : 805 - 812.
  • 10Gustafson KR, Sowder RC, Henderson LE, et al. Isolation, primary sequence determination, and disulfide bond structure of cyanovirin- N, an anti-HIV ( human immunodeficiency virus) protein from the cyanobacterium nostocellipsosporum [ J ]. Biochem Biophys Res Commun, 1997, 238(1): 223 -228.

二级参考文献20

  • 1刘玉生,李昌,金宁一,于芳,金洪涛.新型抗病毒蛋白CVN的构建及原核表达[J].免疫学杂志,2007,23(4):395-398. 被引量:3
  • 2Boyd MR, Gustafson KR, McMahon JB, et al. Discovery of cyanovirin-N, a novel human immunodeficiency virusinactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development. Antimicrob Agents Chemother, 1997, 41: 1521-1530.
  • 3Yang F, Bewley CA, Louis JM, et al. Crystal structure of cyanovirin-N, a potent HIV-inactivating protein, shows unexpected domain swapping. J Mol Biol, 1999, 288(3): 403-412.
  • 4Helle F, Wychowski C, Vu-Dac N, et al. Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans. JBiol Chem, 2006, 281(35): 25177-25183.
  • 5Smee DF, Wandersee MK, CheckeRs MB, et al. Influenza A (H1N1) virus resistance to cyanovirin-N arises naturally during adaptation to mice and by passage in cell culture in the presence of the inhibitor. Antivir Chem Chemother, 2007, 18(6): 317-327.
  • 6Barrientos LG, Gronenborn AM. The highly specific carbohydrate-binding protein cyanovirin-N: structure, anti-HIV/Ebola activity and possibilities for therapy. Mini Rev Med Chem, 2005, 5(1): 21-31.
  • 7Barrientos LG, Louis JM, Rather DM, et al. Solution structure of a circular-permuted variant of the potent HIV-inactivati-ng protein cyanovirin-N: structural basis for protein stability and oligosaccharide interaction. J Mol Biol, 2003, 325(1): 211-223.
  • 8Sexton A, Drake PM, Mahmood N, et al. Transgenic plant production of cyanovirin-N, an HIV microbicide. FASEB J, 2006, 20: 356-358.
  • 9Mori T, Gustafson KR, Pannell LK, et al. Recombinant production of cyanovirin-N, a potent human immunodeficiency virus-inactivating protein derived from a cultured cyanobacterium. Protein Express Purif, 1998, 12 (2): 151-158.
  • 10Moil T, Barrientos LG, Han Z, et al. Functional homologs of cyanovirin-N amenable to mass production in prokaryotic and eukaryotic hosts. Protein Express Purif, 2002, 26(1): 42-49.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部